Article
The First Successful Desensitization Protocol in Exenatide Allergy: A Case Report
2022-10-05
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Glucagon-like peptide-1 (GLP-1) receptor agonists are important treatment options in obese patients with type 2 diabetes. To date, few immediate allergic reactions due to GLP1 analogues were reported. One report revealed that a patient with an immediate hypersensitivity reaction due to exenatide was able to tolerate liraglutide, the alternative GLP-1 receptor ag...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 405e928b-ed85-5c26-9062-499fa1d4a0ab
- DOI
- 10.21203/rs.3.rs-2059070/v1
